These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35938149)

  • 1. Encephalopathy induced by high levels of ceftriaxone in the blood and cerebrospinal fluid.
    Minamii T; Shimizu H; Irie K; Nishioka H
    IDCases; 2022; 29():e01581. PubMed ID: 35938149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid.
    Nishioka H; Cho Y; Irie K; Kanamori M
    Int J Infect Dis; 2022 Mar; 116():223-225. PubMed ID: 35063677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.
    Suzuki S; Naito S; Numasawa Y; Asada M; Shoji N; Zeniya M; Takahashi D; Sato H; Iimori S; Nomura N; Sohara E; Okado T; Ishiwata Y; Nagata M; Rai T; Yokota T; Uchida S
    Intern Med; 2019 Jun; 58(12):1775-1779. PubMed ID: 30799339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone-induced Encephalopathy: A Pharmacokinetic Approach.
    Jadot L; Judong A; Canivet JL; Lorenzo-Villalba N; Damas P
    Eur J Case Rep Intern Med; 2021; 8(11):003011. PubMed ID: 34912745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced encephalopathy in a patient with multicentric glioma.
    Anto M; Iyer RS; Manuel A; Jayachandran A; Jose R; John N; Shyam P; Thankachan A; Thomas SG; Bahuleyan B
    Surg Neurol Int; 2022; 13():303. PubMed ID: 35928317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients.
    Onogi C; Osada A; Imai K; Mimura T; Saka Y; Urahama Y; Oishi H; Naruse T
    Hemodial Int; 2022 Jul; 26(3):E27-E30. PubMed ID: 35441472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic Encephalopathy in a Patient With Metastatic Lung Cancer: A Case Study.
    Rowley SM
    J Adv Pract Oncol; 2018 Mar; 9(2):216-221. PubMed ID: 30588355
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumococcal meningitis with normal cerebrospinal biochemistry and no pneumococci at microscopy, mimicking a stroke: a case report.
    Ertner G; Christensen JR; Brandt CT
    J Med Case Rep; 2017 Jun; 11(1):150. PubMed ID: 28592301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare complication of ceftriaxone therapy: drug-induced thrombocytopenia (DITP).
    Sharma A; Mannuru D; Matta A; Kaushal A
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34489258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible Choreoathetosis in a Patient with End-stage Renal Disease from Administration of Ceftriaxone.
    Tan ML; Tun WWW
    Cureus; 2019 Sep; 11(9):e5764. PubMed ID: 31723523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid.
    Nishikubo M; Kanamori M; Nishioka H
    Antibiotics (Basel); 2019 Jun; 8(2):. PubMed ID: 31212864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.
    Latif R; Dajani AS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):46-8. PubMed ID: 6299184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversible white matter lesions and antithyroid antibodies in the cerebrospinal fluid in Hashimoto's encephalopathy: a case report].
    Wakai M; Nishikage H; Goshima K
    Rinsho Shinkeigaku; 2004 Jul; 44(7):432-7. PubMed ID: 15384704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of protein levels on the cerebrospinal fluid distribution of ceftazidime & ceftriaxone in the cerebrospinal fluid of patients with inflamed meningitis.
    Ichinose N; Yoshikawa G; Fukao E; Takahata T; Ichisawa M; Enoki Y; Taguchi K; Oda T; Tsutsumi K; Matsumoto K
    J Infect Chemother; 2022 Aug; 28(8):1216-1219. PubMed ID: 35513971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database.
    Yamada T; Mitsuboshi S; Suzuki K; Nishihara M; Neo M
    Int J Clin Pharm; 2022 Aug; 44(4):1067-1071. PubMed ID: 35449346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.
    Yokoyama Y; Hosokawa N; Kudo T; Goda H; Ito K; Suzuki M; Funakoshi R
    J Infect Chemother; 2020 Mar; 26(3):285-288. PubMed ID: 31680037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.
    Hagiya H; Miyawaki K; Yamamoto N; Yoshida H; Kitagawa A; Asaoka T; Eguchi H; Akeda Y; Tomono K
    Intern Med; 2017 Nov; 56(22):3103-3107. PubMed ID: 28943562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-induced encephalopathy in a patient with a solitary kidney.
    Futagi Y; Ito Y; Nakade J; Fujita A; Shimada T; Yoshida M; Takahashi Y; Kawano M; Taniguchi T; Sai Y
    Int J Infect Dis; 2022 Sep; 122():722-724. PubMed ID: 35843497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.